Eaton Vance Management Trims Stake in Express Scripts Holding Co (ESRX)

Eaton Vance Management reduced its stake in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 11.2% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 54,447 shares of the company’s stock after selling 6,886 shares during the period. Eaton Vance Management’s holdings in Express Scripts were worth $5,173,000 at the end of the most recent reporting period.

Several other institutional investors also recently added to or reduced their stakes in the company. TRUE Private Wealth Advisors bought a new position in Express Scripts in the 3rd quarter worth approximately $115,000. Palo Capital Inc. bought a new position in Express Scripts in the 3rd quarter worth approximately $124,000. Landaas & Co. WI ADV bought a new position in Express Scripts in the 2nd quarter worth approximately $102,000. Sun Life Financial INC boosted its holdings in Express Scripts by 758.8% in the 2nd quarter. Sun Life Financial INC now owns 1,520 shares of the company’s stock worth $117,000 after buying an additional 1,343 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. boosted its holdings in Express Scripts by 3,048.1% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,637 shares of the company’s stock worth $126,000 after buying an additional 1,585 shares during the period. 85.02% of the stock is owned by hedge funds and other institutional investors.

Shares of NASDAQ:ESRX opened at $95.85 on Friday. The company has a quick ratio of 0.65, a current ratio of 0.77 and a debt-to-equity ratio of 0.63. Express Scripts Holding Co has a one year low of $66.93 and a one year high of $101.73. The firm has a market capitalization of $55.25 billion, a price-to-earnings ratio of 13.50, a PEG ratio of 1.23 and a beta of 0.88.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.42 by $0.01. Express Scripts had a net margin of 4.83% and a return on equity of 25.43%. The firm had revenue of $25.56 billion during the quarter, compared to the consensus estimate of $25.11 billion. During the same period last year, the firm earned $2.51 EPS. The business’s quarterly revenue was up 3.6% compared to the same quarter last year. On average, equities analysts expect that Express Scripts Holding Co will post 9.08 earnings per share for the current fiscal year.

In other Express Scripts news, Director Mahon Thomas P. Mac sold 5,234 shares of the firm’s stock in a transaction on Wednesday, November 7th. The shares were sold at an average price of $99.50, for a total value of $520,783.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.79% of the stock is owned by company insiders.

Several research analysts recently commented on ESRX shares. Zacks Investment Research reaffirmed a “buy” rating and issued a $109.00 price objective on shares of Express Scripts in a report on Tuesday, November 13th. BidaskClub raised shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Tuesday, September 18th. ValuEngine raised shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Monday, September 17th. Royal Bank of Canada set a $101.00 price objective on shares of Express Scripts and gave the stock a “buy” rating in a report on Thursday, November 1st. Finally, Cowen reaffirmed a “buy” rating and issued a $88.00 price objective on shares of Express Scripts in a report on Friday, November 2nd. One research analyst has rated the stock with a sell rating, fourteen have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $92.14.

WARNING: “Eaton Vance Management Trims Stake in Express Scripts Holding Co (ESRX)” was posted by American Banking News and is the property of of American Banking News. If you are reading this story on another publication, it was illegally copied and republished in violation of U.S. and international copyright and trademark laws. The original version of this story can be viewed at https://www.americanbankingnews.com/2018/12/08/eaton-vance-management-trims-stake-in-express-scripts-holding-co-esrx.html.

Express Scripts Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

See Also: What is a Market Correction?

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply